Skip to main content
. Author manuscript; available in PMC: 2013 Jan 1.
Published in final edited form as: Pharmacol Biochem Behav. 2011 Sep 25;100(3):607–615. doi: 10.1016/j.pbb.2011.09.009

Fig. 1.

Fig. 1

Development of ALO AIMs and rotations during L-DOPA priming in DA (n = 7) and DA + NE (n = 12) lesioned rats. Rats were primed with 12 mg/kg L-DOPA + 15 mg/kg benserazide for 7 consecutive days and ALO AIMs and rotations were scored for 1 min every 10 min for 3 h on days 1, 4, and 7. Differences in ALO AIMs between DA and DA + NE rats were analyzed on each day using nonparametric Mann Whitney U-test whereas a 2 (Lesion) × 3 (Day) ANOVA was used to determine potential differences in rotations. DA + NE-lesioned rats showed fewer ALO AIMs on day 1 (A) and less rotations on days 1, 4, and 7 (B). *P<0.05 vs. DA + NE Lesion on same day of testing. Data presented as median ALO AIMs ± M.A.D or Rotations ± S.E.M.